These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 2242038)
1. Anti-oxidative profile of lobenzarit disodium (CCA). Cynshi O; Saitoh M; Cynshi F; Tanemura M; Hata S; Nakano M Biochem Pharmacol; 1990 Nov; 40(9):2117-22. PubMed ID: 2242038 [TBL] [Abstract][Full Text] [Related]
2. Regulation of B cell function by lobenzarit, a novel disease-modifying antirheumatic drug. Hirohata S; Shinohara S; Inoue T; Miyamoto T; Lipsky PE Arthritis Rheum; 1992 Feb; 35(2):168-75. PubMed ID: 1734906 [TBL] [Abstract][Full Text] [Related]
3. Lobenzarit disodium (CCA) inhibits in vitro immunoglobulin production via direct interaction with B lymphocytes. Takeda Y; Urakawa K; Sakamoto A; Nakano T; Sugawara Y; Ohsugi Y; Morita M; Kasahara T Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):177-81. PubMed ID: 1576670 [TBL] [Abstract][Full Text] [Related]
4. Regulation of in vitro anti-DNA antibody production by a novel disease modifying anti-rheumatic drug, Lobenzarit. Hirohata S Clin Exp Rheumatol; 1992; 10(4):357-63. PubMed ID: 1356678 [TBL] [Abstract][Full Text] [Related]
5. HTHQ (1-O-hexyl-2,3,5-trimethylhydroquinone), an anti-lipid-peroxidative compound: its chemical and biochemical characterizations. Hino T; Kawanishi S; Yasui H; Oka S; Sakurai H Biochim Biophys Acta; 1998 Sep; 1425(1):47-60. PubMed ID: 9813237 [TBL] [Abstract][Full Text] [Related]
6. The effect of mefenamic acid and flufenamic acid on plasma uric acid levels. Latham BA; Radcliff F; Robinson RG Ann Phys Med; 1966 Aug; 8(7):242-3. PubMed ID: 5918265 [No Abstract] [Full Text] [Related]
7. Immunopharmacological study of CCA (Lobenzarit disodium), an anti-arthritis agent--I. Abrogation of IL 1 secretion by LPS-stimulated human monocytes and induction of gamma-interferon production with CCA. Fujimoto M; Sugawara I; Kimoto M; Ishizaka S; Tsujii T Int J Immunopharmacol; 1986; 8(3):323-8. PubMed ID: 3089953 [TBL] [Abstract][Full Text] [Related]
8. The effect of diphenylamine derivatives on arachidonic acid metabolism in rat peritoneal macrophages. Ohuchi K; Watanabe M; Fukui Y; Hirasawa N; Ozeki T; Tsurufuji S Prostaglandins Leukot Med; 1987 Jun; 28(1):15-23. PubMed ID: 3112805 [TBL] [Abstract][Full Text] [Related]
9. Biochemical properties of anti-inflammatory drugs. XI. Structure-action relationship for the uncoupling of oxidative phosphorylation and inhibition of chymotrypsin by N-substituted anthranilates and related compounds. Whitehouse MW Biochem Pharmacol; 1967 May; 16(5):753-60. PubMed ID: 6036726 [No Abstract] [Full Text] [Related]
10. New immunomodulator lobenzarit disodium (CCA): activation of IgE class-specific suppressor T lymphocytes and regulation of IgE antibody response enhanced by sublethal X-irradiation in SJL/J mice. Yamashita Y; Nakano T; Ohsugi Y Int Arch Allergy Appl Immunol; 1987; 83(3):296-302. PubMed ID: 2954916 [TBL] [Abstract][Full Text] [Related]
11. The effect of N-(2-carboxyphenyl)-4-chloroantranilic acid disodium salt (CCA) on concanavalin A-induced superoxide anion release in human mononuclear phagocytes. Matsubara T; Minakuchi R; Tanaka Y; Hirohata K Clin Exp Rheumatol; 1986; 4(3):243-7. PubMed ID: 3021365 [TBL] [Abstract][Full Text] [Related]
12. Effects of the fenamates on the threshold of pain. Haward LR Ann Phys Med; 1966; Suppl():55-7. PubMed ID: 4895007 [No Abstract] [Full Text] [Related]
13. Current views on the pharmacological properties of the immunomodulator, lobenzarit disodium. González R; Remírez D J Investig Allergol Clin Immunol; 1997; 7(2):77-82. PubMed ID: 9161931 [TBL] [Abstract][Full Text] [Related]
14. A novel antiarthritic agent, CCA (lobenzarit disodium), and the role of thymus-derived lymphocytes in the inhibition of rat adjuvant arthritis. Ohsugi Y; Nakano T; Hata S Immunopharmacology; 1983 Jun; 6(1):15-21. PubMed ID: 6603446 [TBL] [Abstract][Full Text] [Related]
15. Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium. Sanger GJ; Bennett A Br J Clin Pharmacol; 1979 Nov; 8(5):479-82. PubMed ID: 508555 [TBL] [Abstract][Full Text] [Related]
16. Biochemical properties of anti-inflammatory drugs. X. The inhibition of serotonin formation in vitro and inhibition of the esterase activity of alpha-chymyotrypsin. Skidmore IF; Whitehouse MW Biochem Pharmacol; 1967 May; 16(5):737-51. PubMed ID: 6036725 [No Abstract] [Full Text] [Related]
17. [Free oxygen radiacals and kidney diseases--part I]. Sakac V; Sakac M Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727 [TBL] [Abstract][Full Text] [Related]
18. Fenamates and the potent inhibition of human liver phenol sulphotransferase. Vietri M; De Santi C; Pietrabissa A; Mosca F; Pacifici GM Xenobiotica; 2000 Feb; 30(2):111-6. PubMed ID: 10718119 [TBL] [Abstract][Full Text] [Related]
19. Antagonism by aspirin and fenamates of bronchoconstriction and nociception induced by adenosine-5'-triphosphate. Collier HO; James GW; Schneider C Nature; 1966 Oct; 212(5060):411-2. PubMed ID: 4381910 [No Abstract] [Full Text] [Related]
20. Thyroid hormone uptake by hepatocytes: structure-activity relationships of phenylanthranilic acids with inhibitory activity. Chalmers DK; Scholz GH; Topliss DJ; Kolliniatis E; Munro SL; Craik DJ; Iskander MN; Stockigt JR J Med Chem; 1993 Apr; 36(9):1272-7. PubMed ID: 8487264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]